6 Podcast Episodes
Michel Ducreux, ESMO 2019 - Treating advanced pancreatic cancer
Michel Ducreux, ESMO 2019 - Treating advanced pancreatic cancer
We joined Michel Ducreux (Gustave Roussy Cancer Campus) at ESMO 2019 to discuss the challenges and recent advances in tr... Read more
15 Apr 2020
•
3mins
Michel Ducreux: New agents/strategies on the horizon in bile duct cancer
Michel Ducreux: New agents/strategies on the horizon in bile duct cancer
Webcast: ESMO 20th World Congress on Gastrointestinal Cancer
20 Jul 2018
•
15mins
Michel Ducreux: What is new in anal cancer in the last 12 months?
Michel Ducreux: What is new in anal cancer in the last 12 months?
Webcast: ESMO 20th World Congress on Gastrointestinal Cancer
20 Jul 2018
•
13mins
Michel Ducreux: New agents/strategies on the horizon in bile duct cancer
Michel Ducreux: New agents/strategies on the horizon in bile duct cancer
Webcast: ESMO 20th World Congress on Gastrointestinal Cancer
20 Jul 2018
•
15mins
Michel Ducreux: What is new in anal cancer in the last 12 months?
Michel Ducreux: What is new in anal cancer in the last 12 months?
Webcast: ESMO 20th World Congress on Gastrointestinal Cancer
20 Jul 2018
•
13mins
Adjuvant cetuximab disappoints again in mCRC: Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC: Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Prof Ducreux talks to ecancertv about data in metastatic colorectal cancer (mCRC) presented for the first time at the ES... Read more
1 Aug 2012
•
7mins